• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于设计可溶性环氧化物水解酶和白三烯A4水解酶双重抑制剂的计算机辅助片段生长策略

Computer-Aided Fragment Growing Strategies to Design Dual Inhibitors of Soluble Epoxide Hydrolase and LTA4 Hydrolase.

作者信息

Hefke Lena, Hiesinger Kerstin, Zhu W Felix, Kramer Jan S, Proschak Ewgenij

机构信息

Institute of Pharmaceutical Chemistry, Goethe-University, Max-von-Laue Strasse 9, D-60438 Frankfurt, Germany.

出版信息

ACS Med Chem Lett. 2020 Apr 8;11(6):1244-1249. doi: 10.1021/acsmedchemlett.0c00102. eCollection 2020 Jun 11.

DOI:10.1021/acsmedchemlett.0c00102
PMID:32551007
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7294724/
Abstract

Multitarget ligands are interesting candidates for drug discovery and development due to improved safety and efficacy. However, rational design and optimization of multitarget ligands is tedious because affinity optimization for two or more targets has to be performed simultaneously. In this study, we demonstrate that, given a molecular fragment, which binds to two targets of interest, computer-aided fragment growing can be applied to optimize compound potency, relying on either ligand- or structure-derived information. This methodology is applied to the design of dual inhibitors of soluble epoxide hydrolase and leukotriene A4 hydrolase.

摘要

由于安全性和有效性的提高,多靶点配体是药物发现和开发中令人感兴趣的候选物。然而,多靶点配体的合理设计和优化是繁琐的,因为必须同时对两个或更多靶点进行亲和力优化。在本研究中,我们证明,给定一个与两个感兴趣的靶点结合的分子片段,可以应用计算机辅助片段生长来优化化合物的效力,这依赖于配体或结构衍生的信息。该方法应用于可溶性环氧化物水解酶和白三烯A4水解酶双重抑制剂的设计。

相似文献

1
Computer-Aided Fragment Growing Strategies to Design Dual Inhibitors of Soluble Epoxide Hydrolase and LTA4 Hydrolase.用于设计可溶性环氧化物水解酶和白三烯A4水解酶双重抑制剂的计算机辅助片段生长策略
ACS Med Chem Lett. 2020 Apr 8;11(6):1244-1249. doi: 10.1021/acsmedchemlett.0c00102. eCollection 2020 Jun 11.
2
Design of Dual Inhibitors of Soluble Epoxide Hydrolase and LTA Hydrolase.可溶性环氧化物水解酶和脂磷壁酸水解酶双重抑制剂的设计
ACS Med Chem Lett. 2019 Oct 30;11(3):298-302. doi: 10.1021/acsmedchemlett.9b00330. eCollection 2020 Mar 12.
3
Systematic Assessment of Fragment Identification for Multitarget Drug Design.系统评估多靶标药物设计中的片段鉴定
ChemMedChem. 2021 Apr 8;16(7):1088-1092. doi: 10.1002/cmdc.202000858. Epub 2021 Feb 4.
4
Characterization of the aminopeptidase activity of epidermal leukotriene A4 hydrolase against the opioid dynorphin fragment 1-7.表皮白三烯A4水解酶对阿片肽强啡肽片段1-7的氨肽酶活性的表征
Br J Dermatol. 1995 Nov;133(5):742-9. doi: 10.1111/j.1365-2133.1995.tb02749.x.
5
Development of a homogeneous time-resolved fluorescence leukotriene B4 assay for determining the activity of leukotriene A4 hydrolase.用于测定白三烯A4水解酶活性的均相时间分辨荧光白三烯B4检测方法的开发。
J Biomol Screen. 2007 Jun;12(4):536-45. doi: 10.1177/1087057107299873. Epub 2007 Mar 23.
6
Leukotriene A5 is a substrate and an inhibitor of rat and human neutrophil LTA4 hydrolase.白三烯A5是大鼠和人中性粒细胞LTA4水解酶的一种底物和抑制剂。
Biochem Biophys Res Commun. 1985 Sep 16;131(2):827-35. doi: 10.1016/0006-291x(85)91314-2.
7
Inhibitors of leukotriene A4 (LTA4) hydrolase as potential anti-inflammatory agents.白三烯A4(LTA4)水解酶抑制剂作为潜在的抗炎剂。
Curr Pharm Des. 2001 Feb;7(3):163-79. doi: 10.2174/1381612013398248.
8
Structural characterization of the covalent attachment of leukotriene A3 to leukotriene A4 hydrolase.白三烯A3与白三烯A4水解酶共价结合的结构表征
Arch Biochem Biophys. 1998 Jun 1;354(1):117-24. doi: 10.1006/abbi.1998.0670.
9
Evidence for a catalytic role of tyrosine 383 in the peptidase reaction of leukotriene A4 hydrolase.酪氨酸383在白三烯A4水解酶肽酶反应中起催化作用的证据。
Eur J Biochem. 1995 Aug 1;231(3):528-34. doi: 10.1111/j.1432-1033.1995.0528d.x.
10
Identification and subcellular localization of leukotriene A4-hydrolase activity in human epidermis.人表皮中白三烯A4水解酶活性的鉴定及亚细胞定位
J Dermatol Sci. 1994 Jun;7(3):191-201. doi: 10.1016/0923-1811(94)90095-7.

引用本文的文献

1
Perspectives on Applications of F-NMR in Fragment-Based Drug Discovery.F-核磁共振在基于片段的药物发现中的应用前景
Molecules. 2024 Dec 5;29(23):5748. doi: 10.3390/molecules29235748.
2
Recent advances from computer-aided drug design to artificial intelligence drug design.从计算机辅助药物设计到人工智能药物设计的最新进展。
RSC Med Chem. 2024 Oct 11;15(12):3978-4000. doi: 10.1039/d4md00522h.
3
Discovery of the sEH Inhibitor Epoxykynin as a Potent Kynurenine Pathway Modulator.发现 sEH 抑制剂 Epoxykynin 作为一种有效的犬尿氨酸途径调节剂。
J Med Chem. 2024 Mar 28;67(6):4691-4706. doi: 10.1021/acs.jmedchem.3c02245. Epub 2024 Mar 12.
4
Cheminformatics and artificial intelligence for accelerating agrochemical discovery.用于加速农用化学品发现的化学信息学与人工智能
Front Chem. 2023 Nov 29;11:1292027. doi: 10.3389/fchem.2023.1292027. eCollection 2023.
5
Fragment-to-Lead Medicinal Chemistry Publications in 2020.2020 年的碎片至先导药物化学出版物。
J Med Chem. 2022 Jan 13;65(1):84-99. doi: 10.1021/acs.jmedchem.1c01803. Epub 2021 Dec 20.
6
Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19.线粒体是开发针对包括新冠肺炎在内的重症肺炎中性粒细胞炎症的新型药物的潜在靶点。
Front Pharmacol. 2021 Jan 29;12:609508. doi: 10.3389/fphar.2021.609508. eCollection 2021.
7
Discovery of Soluble Epoxide Hydrolase Inhibitors from Chemical Synthesis and Natural Products.从化学合成和天然产物中发现可溶性环氧化物水解酶抑制剂
J Med Chem. 2021 Jan 14;64(1):184-215. doi: 10.1021/acs.jmedchem.0c01507. Epub 2020 Dec 28.
8
Small Molecule Soluble Epoxide Hydrolase Inhibitors in Multitarget and Combination Therapies for Inflammation and Cancer.小分子可溶环氧化物水解酶抑制剂在炎症和癌症的多靶点和联合治疗中的应用。
Molecules. 2020 Nov 24;25(23):5488. doi: 10.3390/molecules25235488.

本文引用的文献

1
Design of Dual Inhibitors of Soluble Epoxide Hydrolase and LTA Hydrolase.可溶性环氧化物水解酶和脂磷壁酸水解酶双重抑制剂的设计
ACS Med Chem Lett. 2019 Oct 30;11(3):298-302. doi: 10.1021/acsmedchemlett.9b00330. eCollection 2020 Mar 12.
2
Leukotriene biosynthetic enzymes as therapeutic targets.白三烯生物合成酶作为治疗靶点。
J Clin Invest. 2018 Jul 2;128(7):2680-2690. doi: 10.1172/JCI97945.
3
Polypharmacology by Design: A Medicinal Chemist's Perspective on Multitargeting Compounds.基于设计的多药理学:药物化学家对多靶标化合物的看法。
J Med Chem. 2019 Jan 24;62(2):420-444. doi: 10.1021/acs.jmedchem.8b00760. Epub 2018 Aug 3.
4
A perspective on multi-target drug discovery and design for complex diseases.复杂疾病多靶点药物发现与设计的视角
Clin Transl Med. 2018 Jan 17;7(1):3. doi: 10.1186/s40169-017-0181-2.
5
Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase.双 5-脂氧合酶激活蛋白和可溶性环氧化物水解酶抑制剂 diflapolin 的药理学特性和体内功效。
Sci Rep. 2017 Aug 24;7(1):9398. doi: 10.1038/s41598-017-09795-w.
6
Thermodynamic properties of leukotriene A hydrolase inhibitors.白三烯A水解酶抑制剂的热力学性质
Bioorg Med Chem. 2016 Nov 1;24(21):5243-5248. doi: 10.1016/j.bmc.2016.08.047. Epub 2016 Aug 26.
7
Structure-activity relationships of amide-phosphonate derivatives as inhibitors of the human soluble epoxide hydrolase.作为人可溶性环氧化物水解酶抑制剂的酰胺 - 膦酸酯衍生物的构效关系
Bioorg Med Chem. 2015 Nov 15;23(22):7199-210. doi: 10.1016/j.bmc.2015.10.016. Epub 2015 Oct 22.
8
Identification of N-ethylmethylamine as a novel scaffold for inhibitors of soluble epoxide hydrolase by crystallographic fragment screening.通过晶体学片段筛选鉴定N-乙基甲胺作为可溶性环氧化物水解酶抑制剂的新型骨架。
Bioorg Med Chem. 2015 May 15;23(10):2310-7. doi: 10.1016/j.bmc.2015.03.083. Epub 2015 Apr 6.
9
PENG: a neural gas-based approach for pharmacophore elucidation. method design, validation, and virtual screening for novel ligands of LTA4H.彭:一种基于神经气体的药效团阐释方法。LTA4H新型配体的方法设计、验证及虚拟筛选。
J Chem Inf Model. 2015 Feb 23;55(2):284-93. doi: 10.1021/ci500618u. Epub 2015 Feb 9.
10
Molecular fingerprint similarity search in virtual screening.虚拟筛选中的分子指纹相似性搜索。
Methods. 2015 Jan;71:58-63. doi: 10.1016/j.ymeth.2014.08.005. Epub 2014 Aug 15.